Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Canatu signs multi-million joint development agreement with DENSO

By Atte RiikolaAnalyst
Canatu

Translation: Original published in Finnish on 4/15/2025 at 7:13 am EEST.

On Monday, Canatu announced that it has signed a one-year joint development agreement with automotive technology and component supplier DENSO (also a major shareholder of Canatu). The agreement aims to improve the electrical conductivity of carbon nanotubes and it builds on the Memorandum of Understanding announced by Canatu in December 2024.

In accordance with Canatu's disclosure policy, the agreement is "medium", i.e., with a revenue effect of 1-5 MEUR, and according to Canatu, the value of the agreement falls into the upper quartile of the range (>3.75 MEUR). Canatu expects the revenue to be recognized during the one-year term of the agreement between April 2025 and March 2026. Canatu believes that joint development work has significant potential for future commercialization opportunities in the longer term (e.g. solar cells), if the development work is successful. The announced agreement did not come as a complete surprise, as the company commented in the outlook section of its financial statement report that it expects its cooperation and future solar cell development work to progress, which would have a positive impact on automotive revenue this year.

The agreement partly supports our forecasts, which assume that Automotive Industry’s revenue will grow by 36% to 3.1 MEUR this year. However, the biggest variable in Canatu's 2025 revenue is the potential new reactor deals in the semiconductor sector and their timing. We have explained this in more detail in our update a few weeks ago. Our view on Canatu remains unchanged following yesterday's news.

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Read more on company page

Key Estimate Figures30.03

202425e26e
Revenue22.022.835.4
growth-%62.1 %3.7 %55.1 %
EBIT (adj.)-4.8-7.5-4.0
EBIT-% (adj.)-21.9 %-32.8 %-11.4 %
EPS (adj.)-0.01-0.11-0.07
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Rarely do tenbaggers stay long at the valuation levels that made them tenbaggers, and one characteristic of this is a very high P/S. For example...
12/10/2025, 9:38 AM
by StockTycoon
5
I certainly wouldn’t value, for example, a medical device company at a P/S of ten or an automotive OEM. You can take as a comparison, for instance...
12/10/2025, 9:23 AM
by Seeras
3
You are now focusing your assessment on the semiconductor sector. In ten years, other fields might also gain momentum. Some of them might even...
12/10/2025, 8:53 AM
by StockTycoon
1
Seriously, that 10X would require a market capitalization of over 3.5 billion. If you look at Canatu’s own estimates of the market size, for...
12/10/2025, 8:38 AM
by Seeras
5
Canatu is indeed a good candidate to become a ten-bagger with a 10-year horizon, as there are other potential applications besides pellicles...
12/9/2025, 8:26 PM
by StockTycoon
3
Does Inderes believe that Cantu’s share price will increase tenfold with a 12% or even greater probability? One might infer something like that...
12/9/2025, 8:04 PM
by Volkkari
1
Look what ended up in the Model Portfolio. We bought Canatu, a manufacturer of advanced carbon nanotubes, as a new company for the Model Portfolio...
12/9/2025, 10:33 AM
by Sijoittaja-alokas
48
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.